Singapore markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.34+0.26 (+2.35%)
At close: 04:00PM EDT
11.25 -0.09 (-0.79%)
After hours: 05:44PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.08
Open11.10
Bid10.43 x 1000
Ask12.39 x 800
Day's range10.94 - 11.42
52-week range4.70 - 16.85
Volume711,963
Avg. volume683,680
Market cap1.013B
Beta (5Y monthly)1.46
PE ratio (TTM)N/A
EPS (TTM)-2.09
Earnings date06 Nov 2023 - 21 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.89
  • Motley Fool

    Why Shares of Avadel Soared This Week

    Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) were up as much as 45.5% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. On Monday, it reported that the Food and Drug Administration (FDA) had approved the company's first product, Lumryz, to treat excessive daytime sleepiness in adults with narcolepsy. The drug, a formulation of sodium oxybate, is the first FDA-approved, once-at-bedtime oxybate for narcolepsy.